Agbedana E O, Yamamoto T, Moriwaki Y, Takahashi S, Suda M, Higashino K
Third Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Afr J Med Med Sci. 1996 Dec;25(4):365-71.
The lipid components of very low density lipoproteins (VLDL) were significantly elevated in the nephrotic rats. Also the nephrotic VLDL particles had a significantly higher ratio of surface lipids (FC + PL) to core lipids (TG + CE) probably indicating production of smaller sized VLDL in the nephrotic rats. Electron microscopy showed VLDL particles with a reduced mean size in the nephrotic rats. The activities of VLDL core lipid synthesizing enzymes were evaluated in experimental nephrotic syndrome. In addition, the effects of exogeneous cholesterol, 25-OH-cholesterol and low density lipoprotein (LDL) on the acyl-coenzyme A: cholesterol acyltransferase (ACAT) activity were investigated as well. ACAT activity in nephrosis was normal, but stimulated to varying extents in the presence of these factors. On the other hand, the acylcoenzyme A:1,2-diacylglycerol acyltransferase (ADGAT) and phosphatidate phosphorylase-activities were significantly increased in the nephrotic rats. The microsomal cholesterol (free and ester) and phospholipid concentrations were normal but the triglyceride level was significantly reduced in the experimental group. We speculate that an excess production of smaller-sized VLDL particles due to altered activities of microsomal lipid synthesizing enzymes may occur in puromycin amino nucleoside induced-nephrotic rats.
极低密度脂蛋白(VLDL)的脂质成分在肾病大鼠中显著升高。此外,肾病性VLDL颗粒的表面脂质(FC + PL)与核心脂质(TG + CE)之比明显更高,这可能表明肾病大鼠中产生了较小尺寸的VLDL。电子显微镜显示肾病大鼠中VLDL颗粒的平均尺寸减小。在实验性肾病综合征中评估了VLDL核心脂质合成酶的活性。此外,还研究了外源性胆固醇、25-羟基胆固醇和低密度脂蛋白(LDL)对酰基辅酶A:胆固醇酰基转移酶(ACAT)活性的影响。肾病时ACAT活性正常,但在这些因素存在下会受到不同程度的刺激。另一方面,肾病大鼠中酰基辅酶A:1,2-二酰甘油酰基转移酶(ADGAT)和磷脂酸磷酸酶活性显著增加。实验组微粒体胆固醇(游离和酯化)和磷脂浓度正常,但甘油三酯水平显著降低。我们推测,在嘌呤霉素氨基核苷诱导的肾病大鼠中,可能由于微粒体脂质合成酶活性改变而过量产生较小尺寸的VLDL颗粒。